Latest Breaking News On - Eurofins discovery - Page 8 : comparemela.com
Fusion Antibodies teams up with Eurofins Discovery to provide antibody development services | 24 August 2021
stockmarketwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockmarketwire.com Daily Mail and Mail on Sunday newspapers.
Global DNA and Gene Chip (Microarrays) Market Increasing Demand With Industry Professionals:Sequenom, Microarrays Inc , F Hoffmann-La Roche Ltd, NextGen Life Sciences Private Limited, bioMérieux SA, Greiner Bio One International GmbH, LC Sciences, LLC – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
(2) Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing announces the acquisition of Beacon Discovery, a preeminent drug discovery and contract research organization (CRO) focused on G-Protein Coupled Receptor (GPCR) research. Beacon Discovery joins Eurofins Discovery, a market leading CRO with the broadest portfolio of validated in vitro pharmacology, ADMET , and chemistry services for integrated drug discovery solutions. The transaction is expected to close in the coming weeks upon fulfilment of customary closing conditions.
Eurofins acquired Beacon Discovery for its innovative approach, years of experience in drug discovery and development as well as their profound expertise in GPCR research, complemented by their unique compound library. The addition of Beacon Discovery supports Eurofins strategy to be the partner of choice to the pharmaceutical industry, providing drug discovery experience, knowledge, and proven success in supporting the di
Eurofins Discovery Bolsters its Leadership for Integrated Drug Discovery
News provided by
Share this article
Share this article
SAN DIEGO, Feb. 3, 2021 /PRNewswire/ Eurofins Discovery, the market leader in pharmacology services and drug discovery products with over forty years providing solutions for the pharmaceutical and biotech industry, announces Paul D. Ratcliffe, PhD, as its leader for its integrated drug discovery business unit, DiscoveryOne™.
Dr. Ratcliffe, a medicinal chemist by training, brings twenty years of drug discovery and development experience working in big and mid-sized Pharma, driving innovation, strategy and project delivery while leading Research teams comprising
in vitro biology, pharmacology, and analytical and medicinal chemistry. Prior to joining Eurofins, Paul has worked for Grünenthal GmBH, Merck Research Laboratories (UK), and AstraZeneca, UK and has been a member of the Association of the British Pharmaceutical Industry Innovation Board.
Wall Street moves higher following fall in jobless claims; GameStop takes a hit after Robinhood intervenes
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.